Question 1

How might empagliflozin help with the side effects I'm experiencing from olanzapine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients clinical trial (NCT05669742). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of empagliflozin that I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients clinical trial (NCT05669742). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients clinical trial (NCT05669742). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects from empagliflozin?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients clinical trial (NCT05669742). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there other treatment options available that I should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients clinical trial (NCT05669742). Contact the study team or your healthcare provider for specific answers.

Question 6

How long will the trial last, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients clinical trial (NCT05669742). Contact the study team or your healthcare provider for specific answers.

What this study is about